|
Elast-Eon™ technology is the product of a decade of fundamental research into biologically stable materials by the Molecular Science Division of the Commonwealth Scientific and Industrial Research Organization (CSIRO) in Melbourne, Australia. |
 |
The copolymer materials that have been developed exhibit many of the advantageous properties of flexible polyurethane elastomers and silicone rubber. That is, they offer outstanding physical and mechanical properties while retaining biological stability and compatibility.
|
|
AorTech has focused its recent activities on establishing applications for the first generation Elast-Eon™ technology. These applications have predominantly been in critical, long-term implantable life supporting devices in the fields of cardiovascular surgery, interventional cardiology, drug-eluting stents and cardiac rhythm management. |
These partnerships have all been characterized by our Melbourne-based technical organization acting as an extension of the partner's device development team.
The next generation of Elast-Eon™ products has been developed within the framework of a strategic alliance with the Molecular Science Division of the Commonwealth Scientific and Industrial Research Organization (CSIRO). These materials technologies are suitable for a range of therapy areas in orthopaedics and plastic surgery, as well as additional applications within the markets mentioned above.
 |
|
 |